Blastomycosis-like pyoderma pathology

Author: Assoc Prof Patrick Emanuel, Dermatopathologist, Auckland, New Zealand, 2013.

Blastomycosis-like pyoderma is a form of pyoderma which elicits an impressive verrucous epidermal reaction and draining sinus. Various bacteria have been implicated as possible causative organisms.

Histology of blastomycosis-like pyoderma

In blastomycosis-like pyoderma, sections usually show a broad verrucous lesion with epidermal papillomatosis which may resemble a keratoacanthoma (figure 1). There may be surface erosion and suppuration (figure 2). Numerous cystic spaces connect with the surface via draining sinuses (figure 3). There may be a pseudo-infiltrative growth pattern as the regenerative epithelium mimics an invasive squamous cell carcinoma (figure 4). Neutrophilic collections are present in the dermis and within squamous islands (figures 5, 6).

Special studies for blastomycosis-like pyoderma

Gram stain and culture studies may reveal bacteria. Staphylococcus aureus is the most frequent causative agent.

Differential diagnosis of blastomycosis-like pyoderma pathology

Keratoacanthoma – The surface epithelial hyperplasia may be difficult to distinguish from a keratoacanthoma.

Blastomycosis – The reaction pattern is very similar. Special stains for fungal forms should be performed.

Atypical mycobacterial infection/sporotrichosis – These infections may also cause a massive epidermal response. Searching for the causative organisms and correlation with the cultures results can be helpful.

Actinic comedonal plaque – May represent a later stage of blastomycosis-like pyoderma. The inflammation is typically less striking and there is usually impressive solar elastosis.

Related information

Email Newsletter

Would you like to receive our dermatology updates by email?


Submit your images

We're seeking high-quality photos of skin diseases.  


Machine diagnosis

Watch DermNet's proposal to create a 'Skin Disease Image Recognition Tool' - winner of the 2017 'Clinicians' Challenge Active Award' by the NZ Ministry of Health and HiNZ.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter